Comparison of quantitative imaging analysis methods to evaluate murine [18F]FLT PET therapy response studies
Open Access
- 26 November 2025
- journal article
- research article
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 24 (1)
Abstract
Background: Positron Emission Tomography (PET) imaging using 3’-deoxy-3’-[F-18] fluorothymidine (FLT) is a valuable non-invasive marker of tumor proliferation. However, variability in imaging protocols and quantitative analysis techniques hampers comparability across preclinical chemotherapy response studies. Methods: To address this issue in preclinical studies, we evaluated two key areas: (1) imaging standardization (2) semi-quantitative analyses, including Standard Uptake Value (SUV) SUV(max) and SUV(mean), and percent injected (%ID)/g. Using standardized methods of animal handling, image acquisition, image reconstruction and analyses, we assessed multiple FLT uptake metrics in three responsive Patient-Derived Xenograft (PDX) models treated with temozolomide/berzosertib or cisplatin/berzosertib. Metrics included: %ID, SUVbw(max), SUVbw(mean) with a Region of Interest (ROI) threshold of 50% of the maximum value [SUVbw(mean-50%)], and the ratios tumor-to-tissue and tumor-to-liver. Statistical comparisons were made using Brown-Forsythe and Kruskal-Wallis ANOVA and unpaired two tailed t-test to assess cohort differences. Results: Across models and timepoints, no statistical difference among analysis techniques were observed except for one outlier at day 3 in one vehicle cohort, likely due to variability in the normalization parameter. SUVbw(max) and SUVbw(mean-50%) showed the strongest ability to differentiate between vehicle and treated cohorts. Conclusion: Semi-quantitative FLT PET metrics can be harmonized across preclinical studies, with caveats in understanding the normalization parameters, with SUV-based metrics preferred and that larger numbers of animals per cohort will be required to power (≥0.8) robust conclusions. These findings support FLT PET standardization in translational imaging.Keywords
Funding Information
- National Cancer Institute
This publication has 30 references indexed in Scilit:
- Preclinical SPECT and PET: Joint EANM and ESMI procedure guideline for implementing an efficient quality control programmeEuropean Journal of Nuclear Medicine and Molecular Imaging, 2024
- The tumor‐to‐liver ratio of the standardized uptake value is a useful FDG‐PET/CT parameter for predicting malignant intraductal papillary mucinous neoplasm of the pancreasAnnals of Gastroenterological Surgery, 2022
- SUV95th as a Reliable Alternative to SUVmax for Determining Renal Uptake in [68Ga] PSMA PET/CTMolecular Imaging and Biology, 2019
- Standardization of Small Animal Imaging—Current Status and Future ProspectsMolecular Imaging and Biology, 2017
- Tumor SUVmax Normalized to Liver Uptake on 18F-FDG PET/CT Predicts the Pathologic Complete Response After Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal CancerNuclear Medicine and Molecular Imaging, 2014
- [18F]FLT: An imaging biomarker of tumour proliferation for assessment of tumour response to treatmentEuropean Journal of Cancer, 2012
- 3′‐deoxy‐3′‐[18F]fluorothymidine positron emission tomography for response assessment in soft tissue sarcomaCancer, 2011
- Instrumentation factors affecting variance and bias of quantifying tracer uptake with PET/CTMedical Physics, 2010
- PET imaging of cellular proliferationRadiologic Clinics of North America, 2005
- Effects of ROI definition and reconstruction method on quantitative outcome and applicability in a response monitoring trialEuropean Journal of Nuclear Medicine and Molecular Imaging, 2004